Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
Crossref DOI link: https://doi.org/10.1007/s11060-015-1975-y
Published Online: 2015-11-07
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koekkoek, Johan A. F.
Dirven, Linda
Heimans, Jan J.
Postma, Tjeerd J.
Vos, Maaike J.
Reijneveld, Jaap C.
Taphoorn, Martin J. B.
Funding for this research was provided by:
St. Jacobusstichting The Hague, Foundation ‘ZOLEON’ and Foundation ‘Chanrone
License valid from 2015-11-07